Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations

International Journal of Laboratory Hematology

Volumn 31, Issue 5, 2009, Pages 484-495

  Van Delft, P ^a   Lenters, E ^b   Bakker Verweij, M ^a   De Korte, M ^a   Baylan, U ^a   Harteveld, C L ^a   Giordano, P C ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c Center for Human and Clinical Genetics   (Netherlands)

Author keywords

Capillary electrophoresis; Diagnosis; HPLC; Sickle cell disease; Thalassaemia

Indexed keywords

HEMOGLOBIN A2; HEMOGLOBIN C; HEMOGLOBIN D; HEMOGLOBIN E; HEMOGLOBIN H; HEMOGLOBIN S;

ARTICLE; BETA THALASSEMIA; CAPILLARY ELECTROPHORESIS; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; ETHNICITY; HEMOGLOBIN DETERMINATION; HEMOGLOBINOPATHY; HETEROZYGOTE DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; NORMAL VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; BETA-THALASSEMIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CAPILLARY; ETHNIC GROUPS; HEMOGLOBINOMETRY; HEMOGLOBINOPATHIES; HEMOGLOBINS; HEMOGLOBINS, ABNORMAL; HUMANS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 70349097978     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01158.x     Document Type: Article

References (20)

1. Aulesa C., Comellas J., Sentis M. &Ortega J.J. (1995) First evaluation of the Variant haemoglobin analyser (Bio- Rad). Sangre (Barcelona) 40, 369-376.
2. Bouva M.J., Harteveld C.L., van Delft P. &Giordano P.C. (2006) Known and new δ globin gene mutations and their diagnostic significance. Haematologica 91, 129-132.
3. Daland G.A. &Castle W.B. (1948) A simple and rapid method for demonstrating sickling of the red blood cells: the use of reducing agents. Journal of Laboratory and Clinical Medicine 33, 1082-1088.
4. 2 in blood samples containing sickle hemoglobin. Annals of Clinical Laboratory Science 30, 430-431.
5. Giordano P.C., Smit J.W., Herruer W., Huisman J.G.J., Pouwels N., Verhoef N., Idema R.N. &Wijermans P. (2006a) Dragerschapsdiagnostiek en preventie van Sikkelcelziekte en Thalassemie major. Aanbevelingen van de werkroep hemoglobinopathieën. Ned Tijdschr Klin Chem Labgeneesk 31, 301-305.
6. Giordano P.C., Maatman R.G., Niessen R.W., van Delft P. &Harteveld C.L. (2006b) β Thalassemia IVS-I-5 (Gf→C) heterozygosity masked by the presence of Hb J-Meerut in a Dutch-Indian patient. Haematologica 91, ECR56
7. lc. International Journal of Laboratory Hematology 29, 42-44.
8. Harteveld C.L., Jebbink M.C.W., van der Lely N., van Delft P., Akkermans N., Arkesteyn S. &Giordano P.C. (2006) α- Thalassemia phenotype induced by the new IVS-II-2 (Tf→A) splice donor site mutation on the α2-globin gene. Hemoglobin 30, 3-7.
9. Harteveld C.L., Versteegh F.G.A., van Leer E.H.G., Starreveld J.S., Kok P.J.M.J., van Rooijen-Nijdam I., van Delft P., Zanella- Cleon I., Becchi M., Wajcman H. &Giordano P.C. (2007) Hb St. Jozef., a Valf→Leu N-terminal mutation leading to retention of the methionine, and partial acetylation found in the globin gene in cis with a -α3.7 thalassemia deletion. Hemoglobin 31, 313-323.
10. Hoyer J.D. &Scheidt R.M. (2005) Identification of hemoglobin variants by HPLC. Clinical Chemistry 51, 1303-1304 (author reply1305).
11. Joutovsky A., Hadzi-Nesic J. &Nardi M.A. (2004) HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clinical Chemistry 50, 1736-1747.
12. Joutovsky A. &Nardi M. (2004) Hemoglobin C and Hemoglobin O-Arab variants can be diagnosed using the Bio-Rad Variant II high-performance liquid chromatography system without further confirmatory tests. Archives of Pathology and Laboratory Medicine 128, 435-439.
13. Kaufmann J.O., Harteveld C.L., van Delft P., Arkesteijn S.G.J., Selles A.W., Kerkhoffs J.L. &Giordano P.C. (2008) Early pregnancy hemoglobinopathy diagnostics in the Dutch city of The Hague. Provisional results and a new hemoglobin variant:Hb Den-Haag [beta45 CD4(Phe > Tyr)]. 11th International Conference on thalassaemia &Haemoglobinopathies 8-11 October, Singapore (in press).
14. 2 levels in beta-thalassaemia trait with coincident iron deficiency. Indian Journal of Pathology &Microbiology 41, 309-313.
15. 2 levels in pseudoxanthoma elasticum. Annales de Dermatologie et de Venereologie 133, 645-651.
16. Mosca A., Paleari R., Ivaldi G., Galanello R. &Giordano P.C. (2009) The role of haemoglobin A(2) testing in the diagnosis of thalassaemias and related haemoglobinopathies. Journal of Clinical Pathology 62, 13-17.
17. 2 and F determination. Clinical Biochemistry 38, 159-165.
18. 2 in human immunodeficiency virus-1-infected patients treated with zidovudine. American Journal of Hematology 43, 86-90.
19. Viprakasit V., Harteveld C.L., Ayyub H., Stanley J.S., Giordano P.C., Wood W.G. &Higgs DR. (2007) A new deletion defect leading to α-thalassaemia in a large Dutch Caucasian family. British Journal of Haematology 136, 662-665.
20. Waters H.M., Howarth J.E., Hyde K., Goldstone S., Cinkotai K.I., Kadkhodaei- Elyaderani M. &Richards J.T. (1998) An evaluation of the Bio-Rad Variant Haemoglobin Testing System for the detection of haemoglobinopathies. Clinical Laboratory Haematology 20, 31-40.